Comment GW Pharmaceuticals and pain continue to dominate cannabinoid clinical trials Features Revealed: drug development companies best positioned to weather future industry disruption
News Should rheumatoid arthritis trials exclude patients based on their Covid-19 vaccine status? Reynald Castañeda
Features Clinical trial operations industry found it harder to fill digital media vacancies in Q1 2022 Data Journalism Team
Comment Can AI-generated prognostic forecasts substitute patients in oncology trials? GlobalData Healthcare
Comment A fourth Covid-19 booster dose may be needed to prevent a return to ‘pandemic phase’ GlobalData Healthcare
Features CRO M&A deals reach new record, but what does this mean for clinical trial sponsors? Reynald Castañeda
Features AI benefits in patient identification and clinical trial recruitment has challenges in sight Urtė Fultinavičiūtė
Features Alopecia areata steals the spotlight in time for possible treatment paradigm shift Reynald Castañeda
Features Covid-19 two years on: persistent symptoms of clinical trial disruption trouble certain therapy areas Andrew Hillman
Comment Myelofibrosis market to see new approvals in 2022, driving market growth GlobalData Healthcare
Comment Slow recruitment due to Covid-19 disruptions continues to climb in 2022 GlobalData Healthcare
Features Pipeline Moves: J&J ends ulcerative colitis trial, further study chances drop Clinical Trials Arena Team
Features Rare Diseases 2021: GlobalData’s Bonnie Bain on embracing disruption in pharma Kezia Parkins